CORRECTING and REPLACING BIO CEO & Investor Conference to Webcast Nektar's Corporate Presentation.

Business Editors/Health/Medical Writers

CORRECTION...by Nektar Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.

SAN CARLOS San Carlos (săn kär`lōs), residential city (1990 pop. 26,167), San Mateo co., W Calif.; inc. 1925. The chief manufactures are plastic products, hardware, and machine parts. , Calif.--(BUSINESS WIRE)--Feb. 23, 2004

In BW5494 issued Feb. 20, 2004: First graph, second sentence of release (dated February 20, 2004) should read: Wednesday, February 25 (sted Tuesday, February 25).

The corrected release reads:

BIO CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. & INVESTOR CONFERENCE TO WEBCAST NEKTAR'S CORPORATE PRESENTATION

Nektar Therapeutics (Nasdaq:NKTR) announced today that its corporate presentation will be webcast live by the BIO CEO & Investor Conference 2004, organized by the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links

BIO Website

, focused on medical biotechnology. The presentation by Dr. Christopher Dr. John R. Christopher, known popularly as "Dr. Christopher" was one of very few nationally prominent doctors of herbal medicine of the middle third of the 20th century, a "dark ages" of herbalism and was responsible for the herbal renaissance of the 1960s. Searcy, Vice President of Corporate Development, may be heard live at www.nektar.com on Wednesday, February 25, at 11:00 a.m. Eastern time, on the investor relations' page, and will be available on that site for 14 days.

Nektar Therapeutics, formerly Inhale in·hale
v.
1. To breathe in; inspire.

2. To draw something such as smoke or a medicinal mist into the lungs by breathing; inspire. Therapeutic Systems, Inc., provides industry-leading drug delivery technologies, expertise and manufacturing to enable the development of high-value, differentiated therapeutics. Nektar's advanced drug delivery capabilities are designed to enable the company's biotechnology and pharmaceutical partners to solve drug development challenges and realize the full potential of their therapeutics, from developing new molecular entities to managing the lifecycles of established products.

COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Feb 23, 2004
Words:	194
Previous Article:	TheraDoc's New Decision-Support Module, Clinical Alerts Assistant, Evaluates Patient Condition to Deliver Timely Alerts and Reminders.
Next Article:	Harte-Hanks to Present at Conferences.

Related Articles
BIO CEO & Investor Conference to Webcast Nektar's Corporate Presentation.
Friedman Billings Ramsey 7th Annual Technology and Growth Investor Conference to Webcast Nektar's Corporate Presentation.
Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Nektar's Corporate Presentation.
BIO CEO & Investor Conference to Webcast Nektar's Corporate Presentation.
Lehman Brothers Seventh Annual Global Healthcare Conference to Webcast Nektar's Corporate Presentation.
SG Cowen 24th Annual Health Care Conference to Webcast Nektar's Corporate Presentation.
UBS 2004 Global Specialty Pharmaceuticals Conference to Webcast Nektar's Presentation.
Friedman Billings Ramsey to Webcast Nektar Presentation at 8th Annual Growth Investor Conference.
BIO CEO & Investor Conference to Webcast Nektar's Corporate Presentation.
Advisory: BIO CEO and Investor Conference to Webcast Nektar Corporate Presentation.